Trinity Capital Inc. (TRIN) News
Filter TRIN News Items
TRIN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TRIN News Highlights
- For TRIN, its 30 day story count is now at 6.
- Over the past 16 days, the trend for TRIN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about TRIN are GENE, LOAN and RYAN.
Latest TRIN News From Around the Web
Below are the latest news stories about TRINITY CAPITAL INC that investors may wish to consider to help them evaluate TRIN as an investment opportunity.
Trinity Capital Inc. Provides $30 Million Growth Capital to Cart.comTrinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $30 million in growth capital to Cart.com, a provider of unified commerce and logistics solutions that enable merchants to sell and fulfill anywhere. |
Trinity Capital Inc. Announces Phoenix Headquarters Expansion, Highlighting Company's Continued Growth and SuccessTrinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced the expansion of its Phoenix headquarters, reaffirming Trinity's longstanding commitment to the region as it continues to scale its business. |
Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene TherapiesTrinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $40 million in term loans to Taysha Gene Therapies, Inc. (NASDAQ: TSHA) ("Taysha"), a clinical-stage gene therapy company, pursuant to a Loan and Security Agreement dated November 13, 2023, by and among Taysha, the lenders party thereto from time to time (the "Lenders"), and Trinity, as administrative agent and collateral agent for th |
Trinity Capital Inc. Continues Life Sciences Growth, Hires Industry Veteran Ryan Kaeding as Managing DirectorTrinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced the appointment of Ryan Kaeding as Managing Director, Life Sciences in San Diego, California. Mr. Kaeding, a veteran in the venture ecosystem, has been supporting venture capital-backed growth-stage companies for 20+ years. |
Trinity Capital Inc. Declares Cash Dividend of $0.50 per Share for the Fourth Quarter of 2023Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity Capital" or the "Company"), a leading provider of diversified financial solutions to growth stage companies, today announced that on December 14, 2023, its Board of Directors declared a cash dividend of $0.50 per share with respect to the quarter ending December 31, 2023. This dividend represents an increase of 2.0% over the regular dividend declared in the prior quarter. |
Trinity Capital Inc. Provides $45 Million Growth Capital to NeurolensTrinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $45 million in growth capital to Neurolens, a company commercializing innovative solutions to optimize vision. |
Trinity Capital Inc. Reports Third Quarter 2023 Financial ResultsTrinity Capital Inc. (Nasdaq: TRIN) ("Trinity Capital" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced its financial results for the quarter ended September 30, 2023. |
Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc.Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $25 million in growth capital to Neuros Medical, Inc., a bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life. |
Trinity Capital Inc. to Participate in the Jefferies 8th Annual BDC SummitTrinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced that members of the executive management team will be participating in the Jefferies 8th Annual BDC Summit on Wednesday, November 15, 2023 in New York. |
These 12%-Plus Dividend Stocks Look Very Attractive Right Now, Analysts SayYear-to-date, markets are up – some 12% for the S&P 500, and 28% for the NASDAQ, even after recent volatility and pullbacks. But there’s worry in the air, and the red flags are flying. A combination of persistently high inflation and interest rates, along with an increasingly dangerous geopolitical situation, has more and more experts calling out warnings. On the domestic policy side, Federal Reserve chairman Jerome Powell said in recent comments, “Inflation is still too high, and a few months o |